(12/20/2021) COVID Readiness For Christmas

(12/20/2021) COVID Readiness For Christmas

Let's discuss the available options before and after the possible exposure to SARS-COV-2 during this holiday season.

Buy me a coffee :-) https://www.buymeacoffee.com/DrMobeenSyed
Become my patron: https://www.patreon.com/mobeensyed?fan_landing=true
Looking to support my educational work? Donate here: https://paypal.me/mobeensyed?locale.x=en_US

References:

Tests that are expected to fail: https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/sars-cov-2-viral-mutations-impact-covid-19-tests

Before the exposure: general measures. Healthy state of immune system.
Correct vitamin D levels: https://pubmed.ncbi.nlm.nih.gov/33512007/
Forest bathing: https://www.researchgate.net/publication/5458955_A_forest_bathing_trip_increases_human_natural_killer_activity_and_expression_of_anti-cancer_proteins_in_female_subjects

Some monoclonal antibodies aren't as effective against Omicron
https://www.pbs.org/newshour/health/omicron-may-sideline-two-leading-drugs-against-covid-19

GlaxoSmithKlein: https://www.sotrovimab.com/?cc=ps_4FYVU9R0NX1040193&mcm=300000&gclid=Cj0KCQiA8ICOBhDmARIsAEGI6o0w-vDVdeUBSFWDYQtjxTANHe_ydQ7dY5u-GCvJomGxaYNaRmT5jksaAvzSEALw_wcB&gclsrc=aw.ds

Pfizer's Paxlovid: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-announces-additional-phase-23-study-results
EMA advice for Paxlovid: https://www.pfizer.com/news/press-release/press-release-detail/ema-issues-advice-potential-early-use-pfizers-novel-covid

Merck's Molnupiravir: https://www.merck.com/news/merck-and-ridgeback-statement-on-positive-fda-advisory-committee-vote-for-investigational-oral-antiviral-molnupiravir-for-treatment-of-mild-to-moderate-covid-19-in-high-risk-adults/
EMA advice for Molnupiravir: https://www.ema.europa.eu/en/news/ema-issues-advice-use-lagevrio-molnupiravir-treatment-covid-19

Monoclonal Antibodies:
Bamlanivimab: https://www.covid19.lilly.com/bam-ete
Regeneron: https://www.regeneron.com/about/perspectives/immunocompromised-covid-treatment
https://www.regeneron.com/medicines/casirivimab-imdevimab

AstraZeneca: https://www.astrazeneca.com/media-centre/press-releases/2021/evusheld-long-acting-antibody-combination-authorised-for-emergency-use-in-the-us-for-pre-exposure-prophylaxis-prevention-of-covid-19.html

Article: https://www.medicalnewstoday.com/articles/pfizer-oral-antiviral-safe-and-effective-against-sars-cov-2

#drbeen #koolbeens #COVID

Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.